Australia is the official Country Partner for the Bengaluru Tech Summit (BTS) 2024 Launch of India’s first GCC policy ...

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in unlocking a big, fast-growing market for its blockbuster franchise.

Novo Nordisk (NVO) has released an update. Don't Miss our Black Friday Offers: Novo Nordisk has launched a share repurchase program, aiming to buy back B shares worth up to DKK 20 billion over a ...

Novo Erases 2024 Gain, Wiping Out $210 Billion in Value Rivalry, supply constraints weigh on obesity drugmaker Danish firm remains Europe’s most valuable, ahead of LVMH ...

Bagmatic NOVO is our new blood collection monitor serving the special needs of mobile blood donations. As a light weight device with outstanding long battery life, it is developed to take a ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Novo Nordisk has asked the FDA to stop compounding ... and effective" semaglutide products, adding: "These drugs are inherently complex to compound safely, and the risks they pose to patient ...

Amazon isn’t the only retailer that has released early deals — check out the top deals from your favourite brands here. To ...

Novo's new obesity therapy Wegovy is significantly expanding the obesity treatment market given its strong efficacy and is poised to remain a key drug in the market until patent expiration in 2032.

Launch of Nipuna Karnataka Logo marked the beginning of a transformative skills initiative. The Karnataka Government signed 6 MoUs with tech companies to bring together global technology leaders to ...

Mechanical Insulation Distributor Expands TopBuild’s Commercial and Industrial Offerings and Builds on Metro Supply’s Strong Customer ...